The Impact of FDA-Approved Novel Agents for Steroid-Refractory Chronic Graft vs. Host Disease on Treatment Patterns and Outcomes-A Single-Center Longitudinal Cohort Analysis. [PDF]
Fridberg G +11 more
europepmc +1 more source
Autologous Gastrointestinal Graft-vs-Host Disease in a Patient With Multiple Myeloma and Hematopoietic Stem Cell Transplantation. [PDF]
Raza H, Naffouj S, Guzman G, Shuja A.
europepmc +1 more source
Umbilical Cord Blood Platelet Lysate Eyedrops for the Treatment of Severe Ocular Surface Disorders in Graft vs. Host Disease Patients: Clinical Study. [PDF]
Gagliano C +9 more
europepmc +1 more source
Improving Outcomes in Chronic Graft-vs-Host Disease. [PDF]
Mitchell SA, Cowen EW.
europepmc +1 more source
Patient-Reported Outcomes and Mortality in Cutaneous Chronic Graft-vs-Host Disease.
Baumrin E +7 more
europepmc +1 more source
Longitudinal Tear Cytokine Biomarkers: An Analysis from the Close Assessment and Testing for Chronic Graft-Versus-Host Disease (CATCH) Protocol. [PDF]
El Jurdi N +6 more
europepmc +1 more source
Risk of Subsequent Vitiligo in Transplant Recipients With Comorbid Graft-vs-Host Disease.
Bang CH +6 more
europepmc +1 more source
Mesenchymal stromal cells in the treatment of pediatric hematopoietic cell transplantation-related complications (graft vs. host disease, hemorrhagic cystitis, graft failure and poor graft function): a single center experience. [PDF]
Pérez-Torres Lobato M +11 more
europepmc +1 more source
Editorial: Advances in ocular surface disease
Hong Qi +5 more
doaj +1 more source

